Travere Therapeutics, Inc. (TVTX)

Travere Therapeutics Revenue

Travere Therapeutics had revenue of $62.90M in the quarter ending September 30, 2024, with 69.56% growth. This brings the company's revenue in the last twelve months to $203.45M, up 57.08% year-over-year. In the year 2023, Travere Therapeutics had annual revenue of $145.24M with 32.69% growth.

• Revenue (ttm): $203.45M
• Revenue Growth: +57.08%
• P/S Ratio: 6.52
• Revenue / Employee: $535,387
• Employees: 380
• Market Cap: 1.50B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	145.24M	35.78M	32.69%
Dec 31, 2022	109.46M	-22.38M	-16.97%
Dec 31, 2021	131.84M	-66.48M	-33.52%
Dec 31, 2020	198.32M	22.98M	13.11%
Dec 31, 2019	175.34M	11.09M	6.75%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.